Shanghai MicroPort MedBot Group Co. Ltd. has announced the successful completion of the placement of new H shares under a general mandate. This strategic move aims to bolster the company's capital and support its growth initiatives. The process involved the issuance of 55,300,000 shares, comprising 30,163,500 sale shares and 25,136,500 placing shares. The company remains committed to expanding its operations and enhancing shareholder value. The executive team, led by Chairman Mr. Sun Hongbin, includes key figures such as Dr. He Chao and Ms. Fang Cong, who continue to drive the company's strategic objectives.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。